BAWEI
837023
XI'AN WONDER
836419
Jiangsu Tiangong Technology
920068
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
CN Stock MarketDetailed Quotes
605090 Jiangxi Jovo Energy
- 25.37
- -0.15-0.59%
Not Open May 15 15:00 CST
16.47BMarket Cap9.64P/E (TTM)
25.58High25.33Low17.92KlotVolume25.51Open25.52Pre Close45.64MTurnover0.28%Turnover Ratio9.78P/E (Static)649.26MShares31.5952wk High1.69P/B16.31BFloat Cap22.9052wk Low28.07Limit Up642.70MShs Float33.87Historical High22.97Limit Down0.98%Amplitude15.36Historical Low0.80Dividend TTM25.47Avg Price8.41KlotAsk3.15%Div YieldTTM100Lot Size8.89KlotBid
Jiangxi Jovo Energy Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -13.41%5.48B | -17.01%22.05B | -12.75%17.05B | 1.99%11.27B | -2.17%6.33B | 10.91%26.57B | -3.31%19.54B | -14.75%11.05B | -7.75%6.47B | 29.56%23.95B |
| Operating revenue | -13.41%5.48B | -17.01%22.05B | -12.75%17.05B | 1.99%11.27B | -2.17%6.33B | 10.91%26.57B | -3.31%19.54B | -14.75%11.05B | -7.75%6.47B | 29.56%23.95B |
| Other operating revenue | ---- | 22.45%1.36M | ---- | 7.89%558.37K | ---- | -45.68%1.11M | ---- | -59.70%517.56K | ---- | -1.54%2.04M |
| Total operating cost | -15.08%4.98B | -17.76%20.57B | -13.15%15.77B | 2.74%10.44B | -1.34%5.86B | 10.30%25.01B | -4.82%18.16B | -16.48%10.17B | -9.02%5.94B | 28.18%22.67B |
| Operating cost | -15.53%4.84B | -18.37%19.99B | -13.78%15.32B | 2.20%10.18B | -1.39%5.73B | 9.34%24.49B | -5.69%17.77B | -17.13%9.96B | -9.20%5.81B | 29.57%22.4B |
| Operating tax surcharges | -2.08%6.78M | 7.35%32.6M | 4.90%22.64M | 2.58%15.07M | -11.46%6.93M | 54.52%30.37M | 76.18%21.58M | 89.58%14.69M | 118.21%7.82M | 43.43%19.65M |
| Operating expense | -0.39%57.24M | 12.21%229.41M | -10.86%169.87M | 14.42%114.53M | 12.05%57.46M | -0.08%204.44M | -13.50%190.57M | -30.65%100.1M | -13.73%51.28M | -7.43%204.6M |
| Administration expense | -8.51%60.32M | 5.81%314.97M | -11.32%194.77M | 10.91%135.07M | 2.05%65.93M | 78.49%297.67M | 96.72%219.63M | 81.86%121.78M | 11.49%64.6M | 29.40%166.77M |
| Financial expense | 476.23%8.87M | 38.81%-10.68M | 232.31%55.2M | 78.43%-7.52M | -148.17%-2.36M | 84.86%-17.45M | 61.29%-41.72M | 51.24%-34.85M | -35.97%4.89M | -393.70%-115.26M |
| -Interest expense (Financial expense) | -34.14%25.63M | 4.51%138.68M | 24.60%110.51M | 37.38%75.65M | 59.85%38.91M | 108.32%132.7M | 95.10%88.7M | 86.96%55.07M | 95.64%24.34M | 59.01%63.7M |
| -Interest Income (Financial expense) | 30.83%-20.27M | 1.87%-118.33M | 4.13%-84.16M | 11.03%-54.87M | -9.75%-29.31M | -77.68%-120.59M | -212.50%-87.79M | -248.47%-61.67M | -223.15%-26.7M | -140.18%-67.87M |
| Research and development | 42.81%3.01M | 133.08%9.82M | --8.53M | --4.33M | --2.11M | --4.21M | ---- | ---- | ---- | ---- |
| Credit Impairment Loss | 71.62%-4.14M | 60.96%-2.7M | -123.26%-13.55M | 51.86%-14.08M | 52.58%-14.59M | 44.46%-6.93M | 79.98%-6.07M | -29.87%-29.24M | -77.07%-30.76M | -193.15%-12.47M |
| Asset Impairment Loss | -6,098.48%-1.19M | 28.60%-66.14M | 102.84%708.34K | 101.12%151.22K | 99.90%-19.12K | -95.95%-92.63M | 18.83%-24.98M | 63.14%-13.48M | 42.63%-19.03M | -26.48%-47.27M |
| Other net revenue | -10.34%47.76M | 681.23%405.12M | 1,017.29%451.85M | 502.85%408.4M | 230.55%53.27M | -90.58%-69.7M | 42.85%-49.26M | -39.21%-101.38M | 21.86%-40.8M | 1.44%-36.57M |
| Fair value change income | -116.60%-881.71K | 94.63%-988.08K | 123.48%5.24M | 95.00%-3.65M | 126.56%5.31M | -43.15%-18.41M | 34.17%-22.33M | -39.87%-72.91M | 40.47%-20M | -118.08%-12.86M |
| Invest income | 134.36%49.01M | 297.21%45.68M | 195.13%50.33M | 439.38%37.8M | 27.77%20.91M | -394.85%-23.16M | -678.45%-52.9M | -130.64%-11.14M | -47.12%16.37M | 108.11%7.86M |
| -Including: Investment income associates | -34.54%6.69M | 36.11%34.51M | 55.29%33.88M | 52.22%19.9M | -1.17%10.22M | 83.77%25.35M | 297.33%21.82M | 2,059.30%13.07M | 800.42%10.35M | 150.80%13.8M |
| Asset deal income | 1,199.80%240.37K | 75,913.18%340.92M | 116,689.56%328.18M | 721,635.14%335.69M | -196.65%-21.86K | -98.21%448.5K | 110.58%281K | -93.96%46.51K | -96.30%22.61K | 1,008.43%25.02M |
| Other revenue | -88.67%4.72M | 24.48%88.35M | 42.64%80.94M | 107.07%52.48M | 230.57%41.67M | 2,151.72%70.97M | 2,330.85%56.74M | 1,865.05%25.35M | 3,281.48%12.61M | -69.78%3.15M |
| Operating profit | 5.63%554M | 26.69%1.89B | 30.01%1.73B | 57.84%1.23B | 6.65%524.47M | 19.60%1.49B | 27.61%1.33B | 9.11%779.75M | 13.12%491.77M | 63.19%1.24B |
| Add:Non operating Income | -96.05%43.91K | 25.40%4.51M | 64.74%3.45M | 48.13%2.79M | -35.15%1.11M | -86.69%3.6M | -91.88%2.09M | -86.69%1.88M | -59.26%1.72M | 554.70%27.04M |
| Less:Non operating expense | -59.55%432.67K | -13.74%4.01M | 84.05%2.63M | 17.69%1.35M | 172.08%1.07M | 303.97%4.65M | 181.01%1.43M | 579.21%1.15M | 223.48%393.16K | 70.51%1.15M |
| Total profit | 5.55%553.61M | 26.82%1.89B | 30.01%1.73B | 57.88%1.23B | 6.37%524.52M | 17.08%1.49B | 24.64%1.33B | 7.12%780.48M | 12.37%493.1M | 65.83%1.27B |
| Less:Income tax cost | 23.59%48.51M | 15.24%198.71M | -4.14%178.37M | 82.33%117.65M | -4.72%39.25M | -2.94%172.43M | 51.60%186.08M | -24.97%64.53M | -9.65%41.19M | 28.43%177.65M |
| Net profit | 4.09%505.1M | 28.33%1.69B | 35.58%1.55B | 55.68%1.11B | 7.38%485.27M | 20.34%1.31B | 21.13%1.14B | 11.42%715.96M | 14.92%451.9M | 74.08%1.09B |
| Net profit from continuing operation | 4.09%505.1M | 28.33%1.69B | 35.58%1.55B | 55.68%1.11B | 7.38%485.27M | 20.34%1.31B | 21.13%1.14B | 11.42%715.96M | 14.92%451.9M | 74.08%1.09B |
| Less:Minority Profit | -118.41%-944.97K | -57.49%3.86M | 23.61%13.04M | 145.73%8.69M | 1,474.44%5.13M | 221.03%9.08M | 562.60%10.55M | 247.84%3.54M | -30.08%325.96K | -64.66%2.83M |
| Net profit of parent company owners | 5.40%506.05M | 28.93%1.68B | 35.69%1.53B | 55.23%1.11B | 6.32%480.14M | 19.81%1.31B | 20.22%1.13B | 11.04%712.42M | 14.98%451.58M | 75.87%1.09B |
| Earning per share | ||||||||||
| Basic earning per share | 3.90%0.8 | 28.44%2.71 | 34.97%2.47 | 54.78%1.78 | 5.48%0.77 | 19.89%2.11 | 20.39%1.83 | 11.65%1.15 | 14.06%0.73 | 61.47%1.76 |
| Diluted earning per share | 4.29%0.73 | 26.67%2.47 | 34.13%2.24 | 51.89%1.61 | 4.48%0.7 | 10.80%1.95 | 9.87%1.67 | 2.91%1.06 | 4.69%0.67 | 61.47%1.76 |
| Other composite income | -301.43%-13.6M | 10.83M | -169.70%-3.44M | 9.63M | 6.75M | 170.52%4.93M | -200.00%-6.98M | |||
| Other composite income of parent company owners | -301.43%-13.6M | --10.83M | -169.70%-3.44M | --9.63M | --6.75M | ---- | 170.52%4.93M | ---- | ---- | -200.00%-6.98M |
| Total composite income | -0.10%491.51M | 29.16%1.7B | 34.70%1.54B | 57.02%1.12B | 8.88%492.02M | 21.11%1.31B | 22.56%1.15B | 12.67%715.96M | 17.00%451.9M | 71.06%1.09B |
| Total composite income of parent company owners | 1.14%492.45M | 29.76%1.69B | 34.80%1.53B | 56.58%1.12B | 7.82%486.89M | 20.59%1.31B | 21.64%1.14B | 12.29%712.42M | 17.06%451.58M | 72.79%1.08B |
| Total composite income of minority owners | -118.41%-944.97K | -57.49%3.86M | 23.61%13.04M | 145.73%8.69M | 1,474.44%5.13M | 221.03%9.08M | 562.60%10.55M | 247.84%3.54M | -30.08%325.96K | -64.66%2.83M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.